Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 25, 2017 9:00 AM 4 min read

ExxonMobil Renews Longstanding Commitment to Fight Malaria

by Business Wire
Follow
XOM Logo
XOMExxon Mobil Corp
$147.480.14%
Overview
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Press Releases

In recognition of World Malaria Day, ExxonMobil announced today that it is renewing support for local and global organizations working to end malaria around the world. Grants made this year will continue ExxonMobil's longstanding support for efforts to fight the disease that, although preventable, treatable and curable, takes the lives of more than 425,000 each year.

ExxonMobil's malaria initiative focuses on advancing science, providing training and building leadership capacity for health workers, as well as delivering lifesaving tools and health services to people at risk of infection.

"Defeating malaria will help build a better, healthier future for people and their communities," said Ben A. Soraci, president of the ExxonMobil Foundation. "ExxonMobil continues to invest in partnerships that advance our scientific understanding of malaria and can translate knowledge into impact."

ExxonMobil works with partners across Angola, Cameroon, Chad, Equatorial Guinea, Nigeria, Papua New Guinea and Tanzania to raise awareness and advocate for solutions to fight the disease. Planned activities and public events include voluntary testing and counseling sessions, mosquito net distribution, community clean-up campaigns, school engagements, and public awareness campaigns.

ExxonMobil has invested a total of $163 million since 2000 when its program began, supporting the delivery of 14.3 million bed nets to prevent mosquito bites, nearly 3 million rapid tests to diagnose the disease, 4.3 million antimalarial treatments and training for nearly 600,000 health workers. ExxonMobil's 2017 grants total $8 million.

"The aspirations are now clear. Countries are aligning around malaria elimination within their borders and their regions," said Dr. Regina Rabinovich, ExxonMobil Malaria Scholar in Residence at Harvard University's T.H. Chan School of Public Health. "Eliminating disease is no simple feat. To make this ambition a reality, we need continued scientific advances to develop new strategies and tools."

2017 grant recipients include:

  • Harvard T.H. Chan School of Public Health, to advance scientific knowledge of the opportunities for and challenges of malaria eradication; ExxonMobil also recently co-sponsored Harvard's "Rethinking Malaria Leadership Forum."
  • ExxonMobil Global Health Scholars program at Oxford, to train the next generation of leaders and researchers working in international health and tropical medicine.
  • Medicines for Malaria Venture, to discover, develop and deliver effective and affordable new antimalarial medicines for vulnerable populations.
  • PATH Malaria Vaccine Initiative, to accelerate the development of malaria vaccines and ensure their availability and accessibility in developing countries.
  • Seed Global Health, to develop health care expertise and skills in countries facing a shortage of health professionals.
  • Worldwide Antimalarial Resistance Network (WWARN), to standardize and facilitate coordinated collection of information and data on antimalarial drug resistance.

Ajuda de Desenvolvimento de Povo para Povo (ADPP), Africare, Friends of the Global Fight, Global Health Corps, Grassroot Soccer, Jhpiego, Malaria No More, Population Services International (PSI), President's Malaria Initiative (PMI) and Special Olympics also received grants for 2017.

About ExxonMobil

ExxonMobil, the largest publicly traded international oil and gas company, uses technology and innovation to help meet the world's growing energy needs. ExxonMobil holds an industry-leading inventory of resources, is among the largest refiners and marketers of petroleum products and its chemical company is one of the largest in the world. For more information, visit www.exxonmobil.com or follow us on Twitter www.twitter.com/exxonmobil.

About the ExxonMobil Foundation

The ExxonMobil Foundation is the primary philanthropic arm of Exxon Mobil Corporation (NYSE:XOM) in the United States. The foundation and corporation engage in a range of philanthropic activities that advance education, promote women as catalysts for economic development and combat malaria. In the United States, ExxonMobil supports initiatives to improve math and science education at the K-12 and higher education levels. In 2015, the ExxonMobil Foundation together with Exxon Mobil Corporation, its divisions and affiliates along with employees and retirees, provided $268 million in contributions worldwide. www.exxonmobil.com/community.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170425005288/en/

XOM Logo
XOMExxon Mobil Corp
$147.480.14%
Overview
Comments
Loading...